Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui Kuai

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
International Journal of Pharmaceutics|September 28, 2011
Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animalsYao Qin, Huali Chen, Qianyu Zhang, et al.
Nature Communications|June 30, 2023
Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunityChaoyu Wang, Ruoshi Zhang, Jia He, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 9, 2025
Synthetic High-Density Lipoprotein Mimicking Nanodiscs with Pt(IV) Prodrug Enable Tumor Targeting and cGAS-STING Pathway Activation for Chemo-ImmunotherapyKun Shang, Dongsheng Tang, Minhui Cui, et al.
Surgery|August 3, 2019
Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancerTon Wang, Chitra Subramanian, Minzhi Yu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 28, 2018
Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapyRui Kuai, Xiaoqi Sun, Wenmin Yuan, et al.
International Immunopharmacology|September 1, 2020
RalA exerts an inhibitory effect on IL-1β/IL-18 secretion by blocking NLRP3 inflammasome activation in levornidazole-treated human THP-1 macrophagesXingqi Wang, Lingshan Gou, Yuzhi Gao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 14, 2020
Synthetic high-density lipoproteins delivering liver X receptor agonist prevent atherogenesis by enhancing reverse cholesterol transportWenmin Yuan, Bilian Yu, Minzhi Yu, et al.
Ebiomedicine|January 24, 2018
Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis RegressionYanhong Guo, Wenmin Yuan, Bilian Yu, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 22, 2022
Systematic evaluation of the effect of different apolipoprotein A-I mimetic peptides on the performance of synthetic high-density lipoproteins in vitro and in vivoWenmin Yuan, Kelsey Ernst, Rui Kuai, et al.
Journal of Biomedical Nanotechnology|July 15, 2014
Increased delivery of doxorubicin into tumor cells using extracellularly activated TAT functionalized liposomes: in vitro and in vivo studyWenmin Yuan, Rui Kuai, Rui Ran, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
International Journal of Pharmaceutics|September 28, 2011
Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animalsYao Qin, Huali Chen, Qianyu Zhang, et al.
Nature Communications|June 30, 2023
Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunityChaoyu Wang, Ruoshi Zhang, Jia He, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 9, 2025
Synthetic High-Density Lipoprotein Mimicking Nanodiscs with Pt(IV) Prodrug Enable Tumor Targeting and cGAS-STING Pathway Activation for Chemo-ImmunotherapyKun Shang, Dongsheng Tang, Minhui Cui, et al.
Surgery|August 3, 2019
Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancerTon Wang, Chitra Subramanian, Minzhi Yu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 28, 2018
Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapyRui Kuai, Xiaoqi Sun, Wenmin Yuan, et al.
International Immunopharmacology|September 1, 2020
RalA exerts an inhibitory effect on IL-1β/IL-18 secretion by blocking NLRP3 inflammasome activation in levornidazole-treated human THP-1 macrophagesXingqi Wang, Lingshan Gou, Yuzhi Gao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 14, 2020
Synthetic high-density lipoproteins delivering liver X receptor agonist prevent atherogenesis by enhancing reverse cholesterol transportWenmin Yuan, Bilian Yu, Minzhi Yu, et al.
Ebiomedicine|January 24, 2018
Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis RegressionYanhong Guo, Wenmin Yuan, Bilian Yu, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 22, 2022
Systematic evaluation of the effect of different apolipoprotein A-I mimetic peptides on the performance of synthetic high-density lipoproteins in vitro and in vivoWenmin Yuan, Kelsey Ernst, Rui Kuai, et al.
Journal of Biomedical Nanotechnology|July 15, 2014
Increased delivery of doxorubicin into tumor cells using extracellularly activated TAT functionalized liposomes: in vitro and in vivo studyWenmin Yuan, Rui Kuai, Rui Ran, et al.
Pageof 5